UNSPSC 51372209: Dextropropoxyphene napsilate

This classification denotes an opioid receptor agonist and opioid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 38M219L1OJ. European Medicines Agency schedules Dextropropoxyphene napsilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01650MIG. Dextropropoxyphene napsilate generally arises in the molecular formula C22H29NO2.C10H8O3S.H2O. The term 'dextropropoxyphene napsilate' is a United States Adopted Name designation.

Most nations, for tariff and trade purposes, schedule dextropropoxyphene napsilate under HS 29221400. SMILES: CCC(=O)O[C@](CC1CCCCC1)(C2CCCCC2)[C@H](C)CN(C)C.C1CCC2CC(CCC2C1)S(=O)(=O)O.O.

UNSPSC 51372209 Dextropropoxyphene napsilate is a Commodity code representing pharmaceutical products, though recent state and local procurement activity under this code does not reflect purchases of dextropropoxyphene itself. Instead, Seminole County, Florida has posted solicitations for naloxone and drug deactivation systems — opioid-reversal and harm-reduction pharmaceuticals and equipment — suggesting that state and local issuers tag related but distinct pharmaceutical and medical-device categories under this code hierarchy. The work state and local governments are actually buying under this code involves procurement of naloxone units and associated drug deactivation systems for community health and emergency response programs, with quarterly delivery requirements and compliance obligations around workplace certification and federal funding rules.

Seminole County, Florida represents the primary recent activity under the code. The county issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023, at 2:00 pm. The contract carries a two-year initial term with an optional one-year renewal, requires unit pricing for each line item, mandates E-Verify compliance and drug-free workplace certification from vendors, and includes potential FEMA funding with associated federal compliance requirements. Vendors must cover all shipping and delivery costs and maintain workers' compensation, commercial general liability, and professional liability insurance. The procurement reflects state and local investment in opioid-response infrastructure in Florida, though the code shows limited broader geographic or jurisdictional activity in the recent-opportunities record.